Pharmaceutical Microbiology Doctoral Program
Pharmaceutical Microbiology doctorate program was opened to the general assembly with the decision of Turkish Higher education council, dated 22nd of August 2013 and numbered article 75850160.104.01.04.6213/45369.
Pharmaceutical Microbiology, studies the properties of microorganisms that cause infections in humans, the diseases caused by microorganisms and microbiological methods for the diagnosis of these diseases. In addition, the production of antimicrobial agents and microbial products, cosmetics and pharmaceuticals microbiological quality control procedures, methods of sterilization-disinfection and general hygiene issues such as interest-enters the Pharmaceutical Microbiology. Our department is an interdisciplinary field of science in the field of Pharmaceutical Microbiology and aims to educate individuals such as pharmacists, basic scientists and researchers assimilated the basic concepts and applications in all areas of the profession. In addition, our department also aims to current research by following the developments closely in the field of Pharmaceutical Microbiology and Medical Microbiology serving public health and transfer the knowledge to the world of science, industry and the society in national and international platform, most effectively.
The students who have successfully completed a minimum of 21 local credits (equivalent to 120 ECTS credits) from thought courses delivered within the graduate programme of the department and in related fields, achieved a CGPA (grade point average) of at least 3.50 out of 4.00 and prepared and successfully defended a thesis are given Doctoral Degree in MEDICAL MICROBIOLOGY field. The candidates applying to Ph.D. programme with an M.A degree should; 1- have diplomas for MA and B.A. degrees, 2- have required scores from ALES and KPDS, 3- have required scores from second-language exams recognized by the Inter-University Committee, 4- be successful in the interview administered by the Department. The candidates applying to Ph.D. programme with a B.A. degree should; 1- have a B.A. degree with 85.00 or more graduation scores on the scale of 100, 2- have scores of minimum 90 points from the related type of ALES, 3- have required scores from second-language exams recognized by the Inter-University Committee, 4- be successful in the interview administered by the Department. Qualification Requirements and Regulations; Ph.D students with a prior M.A degree should; 1- attend courses of the accepted Department or related departments with minimum 21 credits (120 ECTS) and at least one seminar and pass them with a minimum score of 80 points, 2- pass the Ph.D. Qualification Test, 3- prepare a written dissertation (120 ECTS) and defend it before a jury of experts for the PhD. degree. Ph.D students with a prior B.A. degree should; 1-attend courses of the accepted Department or related departments with minimum 42 credits (150 ECTS) and at least one seminar and pass them with a minimum score of 80 points, 2- pass the Ph.D. Qualification Test, 3- prepare a written dissertation (150 ECTS) and defend it before a jury of experts for the PhD. degree. Students who successfully complete the Ph.D. programme and meet the requirements of the courses can have a further academic career by being employed in the University as a faculty member meeting the requirements of “Faculty Members Acceptance and Preferment Criteria”. In addition, they can apply to post-doc programmes.
| Graduates can find the opportunity to work in quality control laboratories in pharmaceutical and cosmetic industries, the provincial control laboratories and research centers. |
Publications in International Scientific Journals(last two years)
2023
58. Saleh, L.; Altıntaş, B.; Filiciotto, L.; Zorlu, Y.; Luque, R.; ülger, M.; Döndaş, H.; Altug, C. Structural assessment of novel spiro-naphthalene-1.2'-[1,3,4]oxadiazol-4-ones prepared under batch and flow chemistry with a concise antifungal and anti(myco)bacterial activity. TETRAHEDRON, 2023, 131, 133231-133231.https://reader.elsevier.com/reader/sd/pii/S0040402022007554?token=74FBE2A44DA9DC38832A66CEAD47E264B9E6A5296F5CA83E7A83B708E9231706B338223346B68D05D250B137D357FDC8&originRegion=eu-west-1&originCreation=20230417074735://
57. Poyraz, S.; Dondas, H.; Sansano, J.; Belveren, S.; Yamalı, C.; Ulger, M.; Yaktubay dondas, N.; Saglık, B.; Pask, C. N-Benzoylthiourea-pyrrolidine carboxylic acid derivatives bearing an imidazole moiety: Synthesis, characterization, crystal structure, in vitro ChEs inhibition, and antituberculosis, antibacterial, antifungal studies. JOURNAL OF MOLECULAR STRUCTURE, 2023, 1273, 134303-134303.
56. Eroğlu, P.; Civaner, M.; Doğan çalhan, S.; ülger, M.; Binzet, R. . ACTA CHIMICA SLOVENICA, 2023, 70, 196-203.
55. özgür, D.; Ersoy, L.; ülger, M.; Tezcan ülger, S.; Aslan, G. . MIKROBIYOLOJI BULTENI, 2023, 57, 207-219.
54. Yalçın özkat, G.; Ersan, R.; ülger, M.; Tezcan ülger, S.; Burmaoğlu, S.; Yıldız, .; Algül, . Design, synthesis, and computational studies of benzimidazole derivatives as new antitubercular agents. JOURNAL OF BIOMOLECULAR STRUCTURE AND DYNAMICS, 2023, 41, 2667-2686.
53. Yaşar, N.; Tezcan ülger, S.; ülger, M.; Arslantürk, A.; Aslan, G.; Köksal, F. The Mutations on embA, embB and embC Gene Region in Ethambutol-Resistant and Susceptible Clinical Mycobacterium tuberculosis Complex Isolates. MIKROBIYOL BUL, 2023, 57, 45-59.
52. Poyraz, S.; Döndaş, H.; Sansano, J.; Belveren, S.; Yamalı, C.; ülger, M.; Döndaş, N.; Sağlık, B.; Pask, C. . JOURNAL OF MOLECULAR STRUCTURE, 2023, 1273, -.
51. Saleh, L.; Altıntaş, B.; Filiciotto, L.; Zorlu, Y.; Luque, R.; ülger, M.; Döndaş, H.; Altuğ, C. . TETRAHEDRON, 2023, 131, -.
50. Gonca, S.; Polat, B.; özay, Y.; özdemir, S.; Küçükkara, .; Atmaca, H.; Dizge, N. . ENVIRONMENTAL TECHNOLOGY, 2023, , -.
2022
49. Demir karakuş, D.; özdemir, S.; Gonca, S.; Karagülle, N. . JOURNAL OF APPLIED POLYMER SCIENCE, 2022, 139, 1-11.
48. Burmaoğlu, S.; Akın kazancıoğlu, E.; Kazancıoğlu, M.; Alagöz, M.; Döğen, A.; Algül, . . POLYCYCLIC AROMATIC COMPOUNDS, 2022, , 1-14.
47. Gonca, S.; özdemir, S.; Tekgül, A.; ünlü, C.; Ocakoğlu, K.; Dizge, N. . ADVANCED POWDER TECHNOLOGY, 2022, 33, 103346-103355.
46. ülger, M.; Tezcan ülger, S.; Bekçi, A.; Nar ötgün, S.; Delialioğlu, N.; Aslan, G. . MIKROBIYOLOJI BULTENI, 2022, 56, 11-24.
45. ülger, M.; Serin, M.; Tezcan ülger, S.; Aslan, G.; Ilvan, A. . JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16, 1166-1173.
44. Haj ersan, R.; Kuzu, B.; Yetkin, D.; Alagöz, M.; Döğen, A.; Burmaoğlu, S.; Algül, . . MEDICINAL CHEMISTRY RESEARCH, 2022, 31, 1192-1208.
43. Yılmaz, .; özdemir, S.; Gonca, S.; şimşek kuş, N.; Kaynarpınar, H. . MONATSHEFTE FUR CHEMIE - CHEMICAL MONTHLY, 2022, 153, 1225-1234.
42. ödemiş, .; özdemir, S.; Gonca, S.; Arslantaş, A.; Ağırtaş, M. . TURKISH JOURNAL OF CHEMISTRY, 2022, 46, 1417-1428.
41. öksüz, Z.; üçbilek, E.; Serin, M.; Yaraş, S.; Temel, G. . ARCHIVES OF VIROLOGY, 2022, 167, 153-161.
40. özgür, D.; Tezcan ülger, S.; Kayar, M.; Biçmen, C.; Aslantürk, A.; ülger, M.; Aslan, G. . MIKROBIYOLOJI BULTENI, 2022, 56, 191-205.
39. Haj ersan, R.; Alagöz, M.; Döğen, A.; Duran, N.; Burmaoğlu, S.; Algül, . . POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42, 3103-3123.
38. Aftab, J.; Farajzadeh, N.; Yenilmez, Y.; özdemir, S.; Gonca, S.; Altuntaş bayır, Z. . DALTON TRANSACTIONS, 2022, 51, 4466-4476.
37. Farajzadeh, N.; çelik, .; Yaşa atmaca, G.; özdemir, S.; Gonca, S.; Erdoğmuş, A.; Burkut koçak, M. . DALTON TRANSACTIONS, 2022, 51, 478-490.
36. Ağırtaş, M.; Cabir, B.; Gonca, S.; özdemir, S. . POLYCYCLIC AROMATIC COMPOUNDS, 2022, 42, 5029-5043.
35. Farajzadeh, N.; Aftab, J.; Yenilmez, Y.; özdemir, S.; Gonca, S.; Altundaş bayır, Z. . NEW JOURNAL OF CHEMISTRY, 2022, 46, 5374-5384.
34. Farajzadeh, N.; çelik, .; özdemir, S.; Gonca, S.; Burkut koçak, M. . NEW JOURNAL OF CHEMISTRY, 2022, 46, 7177-7186.
33. Gümüşgöz çelik, G.; Gonca, S.; şahin, B.; özdemir, S.; Atilla, D.; Gürek, A. . DALTON TRANSACTIONS, 2022, 51, 7517-7529.
32. Küçükosman, R.; ışık, Z.; özdemir, S.; Gonca, S.; Ocakoğlu, K.; Dizge, N. . BIONANOSCIENCE, 2022, 12, 804-813.
31. Farajzadeh, N.; özdemir, S.; Gonca, S.; Yaşa atmaca, G.; Erdoğmuş, A.; Altundaş bayır, Z.; Burkut koçak, M. . PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2022, 98, 894-906.
30. Atsü, A.; Ergin, .; Caf, N.; Türkoğlu, Z.; Döğen, A.; Ilkit, M. . MYCOSES, 2022, 65, -708.
29. Demirci, .; Gonca, S.; Tolan, V.; özdemir, S.; Dizge, N.; Kılınç, E. . CATALYSTS, 2022, 12, -.
28. Gonca, S.; özdemir, S.; ışık, Z.; M'barek, I.; Shaik, F.; Dizge, N.; Balakrishnan, D. . FOOD AND CHEMICAL TOXICOLOGY, 2022, 165, -.
27. Geçgel, C.; Gonca, S.; Turabik, M.; özdemir, S. . MATERIALS TODAY SUSTAINABILITY, 2022, 19, -.
26. Eskikaya, B.; Arslan, H.; özdemir, S.; Gonca, S.; Dizge, N. . WATER AIR SOIL POLLUT, 2022, 233, -.
25. Belibagli, P.; ışık, Z.; özdemir, S.; Gonca, S.; Dizge, N.; Awasthi, M.; Balakrishnan, D. . CHEMOSPHERE, 2022, 308, -.
24. Gonca, S. . CURRENT MICROBIOLOGY, 2022, 79, -.
23. Arslan, H.; Gonca, S.; ışık, Z.; özdemir, S.; Yalvaç, M.; Dizge, N.; Deepanraj, B.; Ashraf, G. . FRONTIERS IN MATERIALS, 2022, 9, -.
22. Erdoğan eliuz, E.; Everest, Z.; Serin, M. . INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH, 2022, , -.
2021
21. Gonca, S.; Arslan, H.; ışık, Z.; özdemir, S.; Dizge, N. . SURFACES AND INTERFACES, 2021, 26, 1-11.
20. özay, Y.; özdemir, S.; Gonca, S.; Canlı, O.; Dizge, N. . ENVIRONMENTAL TECHNOLOGY & INNOVATION, 2021, 24, 1-13.
19. Gonca, S.; Serin, M.; Yılmaz, A.; Oktay, .; Serin, A.; öksüz karaarslan, Z. . JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14, 1-8.
18. Sert, B.; Gonca, S.; özay, Y.; Harputlu, E.; özdemir, S.; Ocakoğlu, K.; Dizge, N. . COLLOIDS AND SURFACES B: BIOINTERFACES, 2021, 205, 1-8.
17. Yuyucu karabulut, Y.; Kuş bozkurt, F.; Türsen, .; Bayram, G.; örekeci temel, G.; Erdal, M. The role of CD1a expression in the diagnosis of cutaneous leishmaniasis, its relationship with leishmania species and clinicopathological features. DERMATOLOGIC THERAPY, 2021, 34, 1-9.
16. Gulbagca, F.; Aygün, A.; Gülcan, M.; özdemir, S.; Gonca, S.; şen, F. . APPLIED ORGANOMETALLIC CHEMISTRY, 2021, 35, 1-9.
15. Uras güngör, .; Güzel kara, S.; ülger, M.; Kökdil, G. . CHEMISTRY OF NATURAL COMPOUNDS, 2021, 57, 136-140.
14. Haj ersan, R.; Bolelli, K.; Gonca, S.; Döğen, A.; Burmaoğlu, S.; Algül, . . PHARMACEUTICAL CHEMISTRY JOURNAL, 2021, 55, 149-158.
13. Ağırtaş, M.; Cabir, B.; Yıldıko, .; özdemir, S.; Gonca, S. . CHEMICAL PAPERS, 2021, 75, 1749-1760.
12. Gonca, S.; özdemir, S.; Yefimova, S.; Tkachenko, A.; Onishchenko, A.; Klochkov, V.; Kavok, N.; Maksimchuk, P.; Dizge, N. . DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47, 1966-1974.
11. Güzel kara, S.; ülger, M.; Kahraman, A. . BOTANICA SERBICA, 2021, 45, 223-231.
10. Saleh, M.; Gonca, S.; ışık, Z.; özay, Y.; Harputlu, E.; özdemir, S.; Yalvaç, M.; Ocakoğlu, K.; Dizge, N. . CERAMICS INTERNATIONAL, 2021, 47, 27710-27717.
9. Poyraz, S.; Belveren, S.; Aydınoğlu, S.; ülger, M.; De cózar, A.; De gracia retamosa, M.; Sansano, J.; Döndaş, H. . BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY, 2021, 17, 2812-2821.
8. ülger, M.; Tezcan ülger, S.; Oktay gültekin, E.; Yabalak, E.; Gülbudak, H.; Delialioğlu, N.; Gizir, A.; Aslan, G. Aloe vera (L.) Burm.f. ve Hypericum perforatum L. Yapraklarından Elde Edilen Bitki Ekstraktlarının İn vitro Antileishmanial Etkisi. KAFKAS UNIV VET FAK DERG, 2021, 27, 363-370.
7. Kaplan, E.; Aktaş, D.; Döğen, A.; Hilmioğlu polat, S.; Gümral, R.; Hagen, F.; Ilkit, M.; De hoog, S. . MYCOPATHOLOGIA, 2021, 186, 41-51.
6. Emre, G.; Doğan, A.; Haznedaroğlu, M.; şenkardeş, .; ülger, M.; şatıroğlu, A.; Can emmez, B.; Tugay, O. . FRONTIERS IN PHARMACOLOGY, 2021, 12, 664500-.
5. Hazır, S.; Yaroğlu, H.; Bayram, G.; Aşkın, A. INVESTIGATION OF THE POSSIBLE ROLE OF POLY (ADP-RIBOSE) POLYMERASE PATHWAY IN NICOTINEEXPOSED TESTICULAR DAMAGE. FRESENIUS ENVIRONMENTAL BULLETIN, 2021, 30, 7542-7550.
4. Pekbelgin karaoğlu, H.; Sağlam, .; özdemir, S.; Gonca, S.; Burkut koçak, M. . DALTON TRANSACTIONS, 2021, 50, 9700-9708.
3. Gonca, S.; Serin, M.; Yılmaz, A.; Oktay, .; Serin, A.; öksüz karaarslan, Z. . JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14, -.
2. Yuyucu karabulut, Y.; Kuş bozkurt, F.; Türsen, .; Bayram, G.; Temel, G.; Erdal, M. . DERMATOLOGIC THERAPY, 2021, 34, -.
1. Hazır, S.; Yıldırım yaroğlu, H.; Bayram, G.; Aşkın, A. . FRESENIUS ENVIRONMENTAL BULLETIN, 2021, , -.
